A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic mutation, study finds.

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...